Key Multiomics Market Trend for 2025-2034: Innovative Single-Cell Multiomics Platforms Transforming Research

"What Is the Future Outlook for the Multiomics Market's Size and Growth Rate?
The size of the multiomics market has seen a quick expansion lately. It is projected to increase from $3.27 billion in 2024 to $3.85 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. The noteworthy growth in the past period is due to factors such as the hike in biomedical research, augmented governmental and private funding, an escalation in chronic disease prevalence, technological progress, and the improvement of computational tools and software for data examination.

The size of the multiomics market is predicted to experience swift expansion in the upcoming years. The value will inflate to $7.38 billion by 2029 at a compound annual growth rate (CAGR) of 17.6%. This predicted growth in the projection period can be linked to advancements in artificial intelligence and machine learning, the broadening of clinical applications, the expanding biopharmaceutical industry, the advent of unified multiomics platforms, and its escalating utilization in agricultural and environmental research. Significant trends during the forecast period are expected to be technological improvements, the introduction of new commercial multiomics platforms, adoption of spatially resolved multiomics analysis, use in biopharmaceutical research and development, and a foray into clinical diagnostics.

What Is Stimulating Growth in the Multiomics Market?
The escalating requirement for tailored healthcare, known as personalized medicine, is anticipated to drive the expansion of the multiomics market. This distinct approach to healthcare, personalized medicine, involves creating bespoke health decisions and treatments centered on each patient's unique genetic, environmental, and lifestyle data. This surge in personalized medicine results from advancements in technology, an increased need for precise therapies, and worldwide healthcare enhancements. By giving a comprehensive overview of a patient's genetic, molecular, and metabolic state, multiomics serves to refine personalized treatments. For example, the Personalized Medicine Coalition, an American non-profit entity, revealed in February 2024 that the FDA had given their approval for 16 innovative individualized treatments for patients living with rare diseases in 2023, which is a significant increase from 6 in 2022. Hence, the emerging need for personalized medicine spurs the development of the multiomics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

Which Key Market Leaders Are Driving Multiomics Industry Growth?
Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

What Are the Emerging Trends in the Multiomics Industry?
Prominent businesses in the multiomics industry are innovating state-of-the-art single-cell multiomics platforms. These platforms aim to facilitate scientists in conducting extensive research without compromising the quality of their samples. Single-cell multiomics platforms combine different omics with the power of artificial intelligence, enabling users to smoothly assess and decipher intricate biological data via high-level algorithms and machine learning methods. For example, in February 2023, Becton, Dickinson, and Company, an American medical device organization, introduced the BD Rhapsody HT Xpress. This is a high-throughput single-cell multiomics platform that allows scientists to segregate, barcode, and examine single cells at a high sample throughput, handling up to eight times more cells compared to earlier BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures zero loss of samples and the flexibility to review multiple samples, and diverse cell sizes and types all at once, including stem cells or cancer cells, thus augmenting researchers' capacity to garner more knowledge in a shorter time frame.

What Are the Main Segments in the Multiomics Market?
The multiomics market covered in this report is segmented -

1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Geographic Area Leads the Multiomics Market?
North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Multiomics Global Market Report?

- Market Size Analysis: Analyze the Multiomics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Multiomics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Multiomics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Multiomics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.